Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010
Date:2/1/2011

therefore has excluded amortization expense for purposes of calculating these non-GAAP measures to facilitate an evaluation of the Company's current operating performance, particularly in terms of liquidity.
  • Foreign exchange on net sales - The impact of foreign exchange is highly variable and difficult to predict. Accordingly, management excludes the impact of foreign exchange for purposes of reviewing regional and divisional revenue growth rates to facilitate an evaluation of the Company's current operating performance and comparison to the Company's past operating performance.

  • Material Limitations Associated with the Use of Non-GAAP Financial Measures

    Non-GAAP net income, non-GAAP net income per diluted share, and regional and divisional revenue growth rates that exclude the impact of foreign exchange may have limitations as analytical tools, and these non-GAAP measures should not be considered in isolation from or as a replacement for GAAP financial measures. Some of the limitations associated with the use of these non-GAAP financial measures are: 

  • Amortization expense and goodwill and other intangible asset impairment charges, though not directly affecting Boston Scientific's cash flows, represent a net reduction in value of goodwill and other intangible assets. The net loss associated with this reduction in value is not included in Boston Scientific's adjusted net income or adjusted net income per diluted share and therefore these measures do not reflect the full effect of the reduction in value of those assets.

  • Acquisition- and divestiture-related charges (credits) reflect economic costs and benefits to the Company and are not reflected in adjusted net income and adjusted net income per diluted share.

  • Items such as restructuring and restructuring-related costs, litigation-related net (credits) charges, and discrete tax items that are excluded from adjusted net income and adjusted net income
    '/>"/>

  • SOURCE Boston Scientific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

    Related medicine technology :

    1. Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System
    2. Boston Scientific Responds to DOJ Civil Lawsuit
    3. Boston Scientific Announces First Use of Blazer® Open-Irrigated Catheter in U.S.
    4. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
    5. Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent
    6. Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan
    7. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2010 Financial Results
    8. Boston Scientific to Acquire Atritech
    9. Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease
    10. Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article
    11. Boston Scientific Completes Acquisition of Sadra Medical
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... , Jan. 23, 2015  Today the U.S. Food ... Bexsero® for the prevention of serogroup B meningococcal ... and Pfizer,s vaccine Trumenba®, which received FDA approval in ... this devastating disease. "I have heard ...
    (Date:1/23/2015)... Markets ( http://www.researchandmarkets.com/research/5dh22x/urinary_catheters ) has announced the ... Foley Catheters, Intermittent Catheters and Male External or Condom ... and Forecast 2014 - 2020" report to their ... market for urinary catheters is experiencing a healthy growth ...
    (Date:1/23/2015)... Inc. (NASDAQ: NWBO )("NW Bio"), a U.S. biotechnology ... solid tumor cancers, announced today that CEO Linda Powers ... Immunotherapy Forum in Washington D.C. ... January 26 at 10:30 a.m. EST at the Grand Hyatt ...
    Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3
    ... Technologies for Surgery , , TEXARKANA, Texas, June ... technology has three Texarkana neurosurgeons leading their industry by ... technique is improving the desired results of surgical interventions ... spine industry are predicting the latest developments in this ...
    ... Clofarabine, Thiarabine Achieves High Cure Rate in a Colorectal Cancer Model ... PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), ... data will shortly be published demonstrating that thiarabine combined with ... by either agent alone. In one colorectal cancer model, 66% of ...
    Cached Medicine Technology:Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries 2Three Surgeons in East Texas Are Successfully Integrating a Novel Stem Cell Procedure for Spine Surgeries 3Access Pharmaceuticals Announces Publication of Thiarabine Combination Data 2Access Pharmaceuticals Announces Publication of Thiarabine Combination Data 3Access Pharmaceuticals Announces Publication of Thiarabine Combination Data 4
    (Date:1/22/2015)... (PRWEB) January 22, 2015 The City of West ... 10 a.m., to commemorate the 42nd anniversary of the Supreme Court ... , “It’s been 42 years since the Roe vs. Wade decision ... still as present as ever,” said City of West Hollywood Councilmember ...
    (Date:1/22/2015)... Houston, TX (PRWEB) January 22, 2015 The ... Pro Bodybuilder Ben Pakulski to increase lean muscle by up ... This has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting ... shows that it is a step-by-step, scientific diet formula that ...
    (Date:1/22/2015)... 22, 2015 Juvent Sports ( http://www.juventsports.com ... 2015 PGA Merchandise Show to bestow a Juvent Sports ... amateur golfer, Arlene McKitrick. The award commemorated and congratulated ... tournament win. She won her first amateur tournament in ...
    (Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the basic ... , Purchasing an accidental death and dismemberment rider for a ... rider provides benefits if the insured dies in an accident. ... of life insurance. , AD&D is not expensive and ...
    (Date:1/22/2015)... 2015 IsoComforter, Inc. has introduced the most ... IsoTube design to treat specific body parts and muscle groups. ... and easy to use patented cold therapy machine with the ... orthopedic and muscle injuries. IsoComforter has become the industry ...
    Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
    ... South Africa's health minister, Manto Tshabalala-Msimang, claims that including garlic, ... of AIDS//. , She declares that she is ... effects of the anti-retroviral drugs. ,This has sparked ... , The minister insisted to the country's parliament that ...
    ... kings in the treatment of many complex problems. According to ... issue of Angiology if pine bark extract Pycnogenol? (pic-noj-en-all) is ... ,The reason and scientific basis behind it is the ... which speeds recovery after physical exercise. ,"With ...
    ... the capital, the MCD today said there was a rise ... as it launched //a special drive to check breeding of ... mosquito breeding, responsible for the spread of the dreaded fever, ... in desert coolers, the Corporation said in a release. ...
    ... Concerned at the effect of the anti-inflammatory drug Dicolofenec ... has decided to withdraw licences for manufacturing it for ... today, the director of the prominent NGO Bombay Natural ... of Drug Controller General Ashwini Kumar's May 11 circular ...
    ... who are exposed to pesticides that is used for killing ... Parkinson’s disease //. ,Parkinson's disease is a disorder of ... may affect movement, speech and posture. ,Mayo Clinic ... Parkinson's disease between 1976 and 1995. ,Men who ...
    ... sole cause of nearly 24% of all diseases in ... Organization (WHO) said // that all this can be ... are extensively seen in developing countries and could be ... diseases which are influenced by hazardous environmental factors are ...
    Cached Medicine News:Health News:A herbal delight for athletes in solving cramp and pain problems 2Health News:A herbal delight for athletes in solving cramp and pain problems 3
    ... Lens enhances iridectomy procedures by providing ... conventional iridectomy lens designs) with exceptional ... this lens has been increased from ... The MagPlus comes standard with LaserWindow ...
    ... The Fundus 20mm is ... Fundus Lens. The Fundus 20mm ... an increased 20mm contact element. ... that the contact element sits ...
    ... re-designed Super Macula® 2.2 offers extremely high ... fovea, while achieving an exceptionally wide 78° ... excellent choice for critical evaluation of the ... for detailed views of the macula and ...
    ... This specially adapted QuadrAspheric design with 10mm ... and management of retinopathy of prematurety (ROP) ... developed to aid the practitioner in the ... as well as those individuals with narrow ...
    Medicine Products: